Goosehead Insurance
GSHD Small CapFinancial Services · Insurance Brokers
Mis à jour: Jun 18, 2026, 22:21 UTC
Price Chart
Indicateurs clés
Valuation Analysis
About the Company
Goosehead Insurance en bref
Goosehead Insurance (GSHD) is currently trading at 32,15 € with a market capitalization of 1,1 Md €. The trailing P/E ratio stands at 32.35x, with a forward P/E of 13.31x. The 52-week range spans from 29,36 € to 93,14 €; the current price is 65.5% below the yearly high. Year-over-year revenue growth stands at +23.3%. The net profit margin stands at 7.95%.
💰 Dividende
Goosehead Insurance currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.
📊 Avis des analystes
12 analystes évaluent Goosehead Insurance (GSHD) au consensus : Acheter. L'objectif de cours moyen est de 56,81 €, soit un potentiel de +76.7% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 38,36 € à 87,18 €.
Goosehead Insurance : la thèse d'investissement en détail
Goosehead Insurance (GSHD) operates in the Financial Services — specifically Insurance Brokers — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.
Le scénario haussier
Revenue is growing at a healthy 23.3% pace year-over-year, suggesting the business model continues to find new customers and pricing power. Earnings growth of 111.9% is outpacing revenue, a sign of operational leverage — fixed costs are being absorbed across a larger base. The combination of a 48.05% gross margin and 16% operating margin shows the business converts revenue into profit efficiently — a hallmark of competitive moat.
Le scénario baissier
Short interest sits at 10.67% of float — a meaningful contingent of professionals is positioned for the share to fall, which deserves attention even if their thesis may turn out to be wrong. Our valuation screen flags the stock as overvalued — current multiples imply the business needs to deliver well above its recent trajectory to justify the price.
À surveiller
- The forward P/E of 13.31x is meaningfully below the trailing 32.35x — analysts expect earnings to step up; the next earnings release is the test.
- The price sits in the lower quartile of the 52-week range — value hunters often start scaling in around this zone if fundamentals hold.
- The analyst consensus price target implies 76.7% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.
Thèse d'investissement : forces et faiblesses
- Forte croissance du CA de 23.3% sur un an
- Consensus des analystes : Buy
- Free cash flow positif
- –Actuellement jugée surévaluée
- –Positions vendeuses élevées (10.67%)
Aperçu technique
Price is below both the 50- and 200-day moving averages, with 50d below 200d — a bearish picture (death-cross alignment).
Profil de risque
The data points to market-like volatility, elevated short interest (10.67%).
Trading Data
Related Stocks in the Same Sector
More Services Financiers stocks
Top peers in the same sector — ranked by market cap.
Where can I buy Goosehead Insurance?
Compare top-rated brokers — low fees, trusted providers, fully regulated.
Live Market Data
Real-time chart, financials, earnings, analysts, insider trades, events & news
